Quantcast

Latest Ascites Stories

2011-07-21 14:08:57

Measures to reduce BMI may improve outcome for cirrhosis patients Researchers from the United States and Europe involved in an NIH-funded multicenter study have determined that increased body mass index (BMI) is an independent predictor of clinical decompensation in patients with compensated cirrhosis, independent of portal pressure and liver function. The findings suggest obesity accelerates cirrhosis progression and measures to reduce BMI could improve the prognosis for patients with...

2011-07-13 00:00:00

ZURICH, Switzerland, July 13, 2011 /PRNewswire/ -- New Technology Expands Treatment Options for Patient With Refractory Ascites Due to Liver Cirrhosis. Dr. Farzana Malik Joins as Vice President of Market Access and Reimbursement. Sequana Medical announced today that it has received CE Mark approval for the commercial sale of its ALFApump(TM) System. Over the coming months, the company will launch the product in selected hepatology and liver transplant hospitals across...

2011-05-30 00:00:00

ZUG, Switzerland, May 30, 2011 /PRNewswire/ -- NovaShunt AG has launched a new corporate identity and product branding to support its goal of leadership in the area of fluid management within the body. The company will now operate as Sequana Medical AG ( http://www.sequanamedical.com) as it prepares for the upcoming launch of the ALFApump(TM) System in Europe. "There were a number of compelling reasons to rebrand NovaShunt," commented Noel Johnson, CEO. "We felt the name 'NovaShunt'...

2011-05-11 00:22:46

Health outcomes explored at DDW 2011 Research being presented at Digestive Disease Week® (DDW) shows that patients taking a blood thinner (clopidogrel) after having polyps removed during colonoscopy were at relatively low risk of bleeding. Another study shows that a new drug that acts as a hormone, teduglutide, increases intestinal absorption for individuals with short bowel syndrome, which may decrease dependence on intravenous fluid and nutritional support in this at-risk...

2011-03-09 05:32:00

ZUG, Switzerland, March 9, 2011 /PRNewswire/ -- NovaShunt AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23.7 million (about $25 million) in a Series B preferred share financing round co-led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund. Existing investors, NeoMed and VI Partners, were also significant participants in the new financing and NeoMed retains its role as the lead investor...

2010-08-02 21:09:24

The peer reviewed guidelines will be available in the September 2010 issue, (Volume 53, No.3) of the Journal of Hepatology and online in advance of publication at http://www.ncbi.nlm.nih.gov/pubmed/20633946 . They also provide recommendations for the management of spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome, which often affect patients with cirrhosis . An estimated 75 percent of patients presenting with ascites in Western Europe and the USA have cirrhosis as the...

2010-05-06 14:30:27

Recent studies have highlighted the importance of hepcidin in iron metabolism, particularly anaemia of chronic disease and iron overload. There have also been reports of its expression in various proinflammatory disorders and various organs, linking it to innate immunity and iron metabolism. To date, hepcidin has only been shown to be present in serum and urine of humans. A research article to be published on May 7, 2010 in the World Journal of Gastroenterology addresses this question. The...

2010-04-27 14:09:18

Presence and type of complications predictors of mortality A recent study by Danish researchers discovered patients with alcoholic cirrhosis had a high prevalence of complications at the time of the disease diagnosis. Researchers noted that complications, such as ascites (excessive fluid in the abdomen), were predictors of mortality, but did not develop in a predictable sequence. Results of this 12-year mortality study appear in the May issue of Hepatology, a journal published by...

2010-02-11 04:40:00

ZUG, Switzerland/>, February 11/> /PRNewswire/ -- NovaShunt today announced the initiation of its pivotal multi- center clinical study named PIONEER, a Prospective, multi-center, open label, non-randomized study to Investigate the safety and perfOrmance of the Automated Fluid ShuNt in patiEnts with ascitEs and diuretic Resistance. The study is designed to evaluate the safety and performance of the Automated Fluid Shunt (AFS) System in replacing the need for paracentesis, the standard...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related